Related Experiment Video
Updated: Jun 12, 2026
10:05
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases
Yaxing Zhang1,2,3, Hongliang Li4,2,3
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Physiology (Bethesda, Md.)
|April 14, 2017
Summary
Interferon regulatory factors (IRFs) are key proteins in immunity and cardiometabolic health. This review explores how IRFs impact innate immunity and metabolic diseases, highlighting altered signaling pathways.
Area of Science:
- Immunology
- Cardiovascular Biology
- Metabolic Research
Background:
- Interferon regulatory factors (IRFs) are conserved proteins with roles beyond the immune system.
- IRFs are crucial for innate immune responses.
- Dysregulated IRF signaling is implicated in various diseases.
Purpose of the Study:
- To review the mechanisms of IRF-mediated innate immunity.
- To elucidate the function and mechanisms of IRFs in cardiometabolic diseases.
- To highlight the role of reprogrammed IRF signaling in homeostasis and disease.
Main Methods:
- Literature review of existing research on IRFs.
- Analysis of IRF function in immune and non-immune tissues.
- Focus on IRF signaling pathways in cardiometabolic contexts.
Main Results:
- IRFs orchestrate critical innate immune responses.
- IRFs play significant roles in maintaining cardiometabolic homeostasis.
- Altered IRF signaling contributes to the pathogenesis of cardiometabolic diseases.
Conclusions:
- IRFs are vital regulators of both innate immunity and cardiometabolic health.
- Understanding reprogrammed IRF signaling offers therapeutic targets for cardiometabolic diseases.
- IRF research bridges immunology and metabolic disease studies.
More Related Videos
Related Concept Videos
01:19Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...